Personalized assent for pediatric biobanks by unknown
DEBATE Open Access
Personalized assent for pediatric biobanks
Noor A. A. Giesbertz1,2*, Karen Melham3, Jane Kaye4, Johannes J. M. van Delden1 and Annelien L. Bredenoord1
Abstract
Pediatric biobanking is considered important for generating biomedical knowledge and improving (pediatric)
health care. However, the inclusion of children’s samples in biobanks involves specific ethical issues. One of the
main concerns is how to appropriately engage children in the consent procedure. We suggest that children should
be involved through a personalized assent procedure, which means that both the content and the process of
assent are adjusted to the individual child. In this paper we provide guidance on how to put personalized
assent into pediatric biobanking practice and consider both the content and process of personalized assent.
In the discussion we argue that the assent procedure itself is formative. Investing in the procedure should be a
requirement for pediatric biobank research. Although personalized assent will require certain efforts, the pediatric
(biobank) community must be aware of its importance. The investment and trust earned can result in ongoing
engagement, important longitudinal information, and stability in/for the research infrastructure, as well as increased
knowledge among its participants about research activity. Implementing personalized assent will both respect the
child and support biobank research.
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Background
Many biobanks, collections of human biological samples
stored for medical-scientific research purposes, include
biological samples from children [1–3]. Pediatric biobank-
ing is considered important for generating biomedical
knowledge and improving (pediatric) health care [4–9].
Typical for biobank research is that samples can be
stored for many years, while linkable to phenotypic
data, and that the exact research questions are often
not formulated at the time of sample inclusion [10]. Be-
cause samples are often stored coded, and not anonym-
ous, and informational risks are involved, ethical (and
legal) guidance is needed on appropriate governance,
such as consent [11, 12]. Since children are not consid-
ered competent and lack the legal capacity to provide
informed consent [13], designing an appropriate con-
sent procedure for pediatric biobanking is even more
challenging. Generally, parents (or legal guardians)
must give permission for the inclusion of their children
in biomedical research. Over the last decades, there has
been a move towards recognition of a child’s right to be
involved in matters that affect him or her and to ex-
press personal views [14]. This right is also recognized
in biomedical research guidelines, specifically in the re-
quirement to seek a child’s assent. Key guidelines state
that when a child is capable to provide assent for par-
ticipation in biomedical research it should be sought
[15–17]. It is considered a necessary, though insuffi-
cient condition for the inclusion of children in research
[15–17]. This view has also been articulated in the con-
text of pediatric biobank research [18–22]. Earlier we,
and others, have argued that assent should be under-
stood from an engagement point of view [23–27].
Assent from an engagement point of view is grounded
in respect for the child’s developing autonomy, promot-
ing of or the support for the development of the child
and as a support for communication between the re-
searcher and child [23]. To fully acknowledge the dif-
ferences between children, the assent procedure needs
to be adjusted to the individual child. We referred to
this as personalized assent [23]. The question follows
how the content and process of an assent procedure
can be formed in accordance to personalized assent.
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Moreover, while personalized assent does justice to the
individual child, it at the same time creates a dilemma.
Accepting a child’s right to personalized assent, as a moral
requirement, implies a moral duty of the researcher to
make his or her best effort to engage the child. However,
this is a positive duty and, without accurate demarcation,
a positive duty can be limitless. It is necessary to deter-
mine which efforts are reasonable to ask from researchers
and how personalized assent can be embedded within the
research context. Without further articulation, personal-
ized assent is at risk of becoming an empty concept. In
this paper we will therefore provide guidance on howto
put personalized assent into pediatric biobanking practice.
Content of personalized assent
The content of the assent procedure refers to the infor-
mation that is discussed with the child. Since assent
must be understood from an engagement point of view,
it follows that the content of the assent procedure is dir-
ectly linked to the individual child’s capacities and
wishes, and therefore varies [23]. For some children it
may only be possible to discuss that a blood sample will
be taken and that she can say no. For more mature
children, the detail of information may be similar to in-
formed consent procedures for adults [26, 27]. Eventu-
ally, the child may decide whether she wants to
participate in the study as she understands it [28].
Which information should be discussed first?
There are several empirical studies on children’s under-
standing of research information and competence to
assent/consent [29]. However, it is problematic to com-
bine and generalize the results of empirical assent stud-
ies, because of the context specific factors that may have
influenced the results [29, 30]. For instance, studies with
one simple intervention or type of measurement are eas-
ier to understand than studies with a comprehensive re-
search program. Studies on the perception of healthy
children found a considerable variation in their under-
standing of the biobank study rationale [31–33]. It was
therefore deemed more appropriate to focus on practical
procedures, like a venipuncture [31]. It seems reasonable
to focus on concrete information first. Concrete infor-
mation is easier to understand than abstract concepts,
such as privacy issues [34, 35]. Moreover, information
about what the short-term experience of the child will
be in the study may be most relevant for the child to
make up her mind about participation. Biobanking typic-
ally consists of three stages: (1) collection and inclusion
of the sample, (2) storage of the sample and (3) usage of
the sample. The first phase of biobank research entails,
for example, a venipuncture or buccal swab. It follows
that generally the first phase will be easier to understand
and should therefore be the starting point in informing
children. The information related to the second and the
third stage of biobank research should be offered to chil-
dren who are able to understand this and moreover,
want to receive more information [26]. This would entail
topics such as privacy issues and details about the type
of studies supported by the biobank.
The process of personalized assent
The process of the assent procedure refers to how infor-
mation is offered and the roles of the different persons
involved.
How to offer information?
An important aspect of the way to offer information is
the choice of means or material used to inform children.
Several means and methods have been suggested to sup-
port the transfer of information, such as pictures, games
and DVDs (Table 1). Making use of different styles, tech-
niques and technical innovation, can be useful.
Currently, information technology (IT) interfaces as
part of participant-centered initiatives (PCI) are being
developed in adult biobanks [36, 37]. These develop-
ments can also be used in pediatric biobanking and can
play a crucial role in maintaining the relation between
the biobank and child (and future adult participant).
Interfaces can be used to communicate with children
over time and help to address an issue like re-
contact. In addition, the quality of biobank research
Table 1 Means and methods to support information transfer
Previously, we and others discussed that combining the classic methods
of written information and verbal explanation increases the child’s
understanding [23, 70] and that these methods should be used in such a
way as to supplement each other [23, 39]. We also suggested the use of
other techniques, e.g. pictures. However, merely adding pictures to written
information does not seem to increase understanding and additional
research is required to optimize communication techniques [71].
One way to improve information provision is the use of stories and/or
characters that children are familiar with. This can be helpful in explaining
even difficult subjects. Harry Potter or the X-men, for example, can be used
to explain genetics and hereditability [72]. Another suggestion is to shape
the assent procedure as an activity [58, 73]. This way children truly become
part of the research discussion and it seems a promising method to
engage them in a way that appeals to them. Examples are creating a
storyboard and playing word games as a way to discuss research [58].
Technical innovations can also be used, particularly since present-day
children have grown up with multimedia. Although one study showed an
increased comprehension of study procedures and risks among children
who received multimedia information [74], a review on the improvement
of understanding of informed consent elements for adults concluded
that multimedia interventions often fail [75]. Moreover, one small study
showed that generally children preferred written information sent to them
individually, instead of being informed through websites or email [60].
Hence, more research is needed on how to use technological innovations
and multimedia effectively. When using multimedia, at least two points
need to be considered. First, multimedia can be implemented in a passive
form, for example showing a DVD, and/or an active form, for example
a computer game. Second, multimedia should not be considered a
substitute for interaction between researcher and child [73].
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can be improved by investing in ongoing contact with the
participating children. Participants are a valuable source
for qualitative, experiential, and longitudinal information.
An interface can be used to obtain such data [36].
The role for adults in the assent procedure
Obviously, there must be a contact moment between the
child and someone who can assess the child’s capacities
and wishes to personalize the assent procedure. Typic-
ally, there is a triangular relationship between the child,
the parent(s) and the researcher [38].
The researcher is an obvious candidate to seek assent
from the child. The researcher is the one who wants to
study the child (or the biological material) and is prob-
ably most knowledgeable about the research. However,
one of the main dilemmas of assigning the role to obtain
personalized assent to the researcher is his or her per-
sonal interest in including the child in the study. It may
be appealing not to invest much effort in informing the
child and elaborating on the child’s opinion. Selecting
research staff who is aware of their responsibility to re-
spect the child and have a sense for working with chil-
dren is therefore indispensable. In addition, training the
persons who will obtain assent is very important. They
should know what the aim of assent is, how to offer in-
formation to children, how to assess their capacities and
wishes and how to act on it [39, 40]. Parents know their
child and may have particular insights into interpreting
verbal and non-verbal signals. Therefore, they can have
an important part in the assent procedure. They can
advise or assist in explaining (parts of ) the study. In
addition, parents may also play an important role in
protecting their child’s right to dissent and/or assent if a
researcher does not take his or her responsibility to
protect these rights [41]. However, it must not be over-
looked that parents can also disrespect their child’s
dissent [31, 41, 42] and can be opposed to their child’s
right to assent or consent [43, 44].
The assessment itself
The next question is how a researcher (or research staff )
can assess the individual child in order to personalize
assent. The first thing that obviously needs to be consid-
ered is whether communication with the child is pos-
sible. When communication is possible, first the basic
research information should be offered. Hereafter, the
researcher needs to find out what the child understands,
what the child wants to know and what the child can
and wants to decide [45]. Factors that are considered to
influence these matters for example are, psychological
state, anxiety, level and types of (research) experience,
health status, maturity, culture, religion, familial and so-
cietal context and complexity of the research [29, 30,
45–50]. During a personal conversation the researcher
should attempt to find out what the child understands
by asking to explain their understanding of the study in
their own words [46]. In addition, researchers need to
listen and respond to the concerns and questions of the
child. The aim of this conversation is for researchers to
ascertain what information is valuable to this particular
child and to try to fit the information to the child’s needs
[45]. Some may say that it is difficult for researchers to
assess children. However, this does not mean that it
should not be strived for [46, 51]. Moreover, some con-
sider assessing a child’s capacities not as difficult as it
may seem [52].
Subjectivity of the assessment
A dilemma with the above approach is that it relies
heavily on the researcher’s capacities and efforts to
optimize the assent procedure. If a researcher fails to in-
vest in the assent procedure sufficiently, there is a risk of
not involving the child at all, or at least not enough. As
discussed, this risk originates from the researcher’s inter-
ests in including the child (or her biological material) in
the research. Therefore, they may not be fully committed
to optimizing the assent procedure. This may be particu-
larly the case where researchers view assent as an extra
and parental consent as the only legal or ethical require-
ment. Furthermore, presumptions of the researcher
about the incapacities of children may lead to failure to
include children in the research discussion [53]. Introdu-
cing a presumption of competence for children as a
starting point in the research discussion about biobank
participation has been suggested as a way to ensure that
children are taken seriously [54]. Further studies of such
an approach and the attitudes of the persons who seek
assent will be valuable. In addition, well-validated tools
to assess a child’s capacities to assent/consent can be
helpful to objectify the assessment outcome [55, 56].
However, since the aim of assent is to engage with chil-
dren, we think there remains a central role for the re-
searcher in the assent procedure.
The reaction of the child
It is reasonably straightforward that an affirmative agree-
ment of the child constitutes assent and that a clear ob-
jection refers to dissent. How should we consider the
grey area between a clear dissent and an affirmative
agreement? It is quite possible that children stay silent
when their parents have given permission for participa-
tion and they feel intimidated [28, 57]. Although chil-
dren are aware of the possibility to dissent, they find it
difficult to say no in reality [32, 33]. Furthermore, when
children do not give a clear answer about whether
they want to participate, it is questionable whether
they have understood the research information [58]. Thus,
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especially when children keep silent, extreme caution
must be exercised before proceeding with the study.
Discussion
Having described the practical considerations for the im-
plementation of personalized assent, several comments
can be made. First, the question arises whether assent is
a strict requirement in pediatric research. An important
distinction here is assent understood as a procedure and
assent understood as the affirmative agreement of the
child. The assent procedure is itself formative; appropri-
ate engagement adds to the integrity of the research re-
lationship and its meaning for both researcher and child.
Only when it is absolutely impossible to follow the
assent procedure, the duty of the personalized assent
procedure may be waived by a research ethics committee
(REC) beforehand, for example in research with new-
borns. Otherwise a researcher must make the effort to
seek assent in practice. Whether an affirmative answer
of the child is required, however, is more complicated. It
is possible that during the assent procedure, it becomes
clear that the child does not have the capacities or desire
to be involved in the decision-making procedure [26, 59].
Since we conclude that not all children can and/or want
to give assent after going through the assent procedure, it
would be strange to impose an affirmative agreement of
the child as a strict requirement on researchers. Therefore,
we argue that provided that other safeguards are in place,
i.e. the requirement of parental permission, strict regula-
tions about acceptable risks, supervision of a REC, the re-
sponsibility of researchers to respect their participants and
respect for dissent [23], a child may be included in a study
without her affirmative agreement. However, this caveat
should not be used as a way to circumvent the general
duty to make the effort to seek assent. In addition, when
there is no affirmative agreement of the child, the onus of
proof is on the researcher to show that he or she did
honor the personalized assent procedure and that it is
justified to continue the research. Note that when the
research population consists of children who are quite
mature and/or the proposed study is reasonably
straightforward, it will be more difficult to prove that
it is justified to continue with the study without an
affirmative agreement.
Second, investing in a personalized assent procedure
can serve two goals. An appropriate involvement of the
child shows respect for the child as a person. It is the
moral (and professional) responsibility of the researcher
to put effort into the engagement of the child in the re-
search discussion and personalized assent [23]. It is in-
teresting to see that children themselves also articulate
some sort of duty on the part of the biobank researcher
to involve them in the research discussion based on reci-
procity: when they participate, researchers have a
responsibility to treat them with respect [60]. It is im-
portant for researchers to be aware of this expectation
and trust: it is another reason to take seriously their re-
sponsibility to engage children. Next to respect for the
child, an appropriate involvement of the child in the re-
search discussion also contributes to the quality and suc-
cess of the research [41, 60]. It may lead to a general
trust in the biobank and children who are well informed
and intrinsically motivated to participate, will probably
provide more accurate information and are likely to par-
ticipate longer [30, 41, 60–62]. This is especially important
for biobanks, since they generally conduct longitudinal re-
search and often want to collect phenotypic information
on a regular basis. Earlier we argued in favor of re-
contacting former child participants when they become
adults, in order to give them the opportunity to withdraw
their samples [63]. When participants can identify them-
selves with the biobank goals, they are probably less likely
to withdraw their samples.
Third, in the introduction we described that the duty
to involve children in the research discussion is a posi-
tive duty and needs further demarcation. The amount of
effort required to invest in the child must be reasonable
[64]. There will be practical limits to this responsibility,
for example the development of interactive games may
be too expensive for small biobanks. Moreover, the ef-
forts required must be proportionate to the study, hence,
to the characteristics of the biobank. For example, taking
a one-time saliva sample for a few measurements differs
considerably from monthly blood withdrawal and pro-
viding information by filling in several questionnaires.
There is also a difference between biobanks that want to
conduct simple tests, like a hemoglobin measurement,
compared to biobanks that want to use DNA sequencing
methods. In general it can be stated that the greater the
burdens and/or higher the risks, the greater the effort
that must be put into the assent procedure.
Fourth, in line with the former remark, ethics govern-
ance can play both a formative and controlling role.
RECs can explain what the underlying aim of assent is
and advise on how to put it into practice. In addition,
they can request a thorough assent policy as part of a re-
search or biobank proposal in order to create a system
of checks and balances [20]. This policy must clearly de-
scribe the entire assent procedure, including data on the
persons who will be obtaining assent and which infor-
mation materials will be used. The proposal should also
discuss the course of action when the child does not give
an affirmative reaction. A local REC can check whether
the proposed assent policy is appropriate and propor-
tionate for that particular biobank.
Fifth, one could argue against personalized assent that
it would be impractical and/or not enforceable [65, 66].
As discussed previously, we are aware that personalized
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assent is an appeal to a researcher’s integrity and that it is
difficult to provide fixed end points [23, 67]. The assent
procedure must be flexible enough to adapt to different
(biobank) studies and the different situations of individual
children, for example, their difference in maturation,
diversity in family dynamics or culture [26, 30, 68]. Re-
searchers must be reminded of their professional responsi-
bility and moral duty to engage children and strive for
empowerment of the individual child [46]. Since biobank
employees reported a natural desire to engage children
in the consent procedure out of respect for the child
[41], we are confident that an appropriate awareness
can be achieved. However, making this duty explicit
and increasing awareness of researchers and biobank
employees is needed.
Last, we want to remark that not only assent, but also
consent procedures can benefit from working from the
engagement point of view. Although informed consent
nowadays gained an important legal function, our view
emphasizes the ethical origins of consent. People differ in
informational interests and in the ways they want to be in-
formed [69]. Viewing consent more from an engagement
point of view may add to honoring these differences.
Conclusions
Personalized assent is aimed at engaging children in ac-
cordance to their personal capacities and desires. The
assent procedure can be designed in order to support
the goal of engaging children. Particularly for biobanks,
the characteristic three phases, i.e. inclusion, storage and
use of samples, provide a natural arrangement of the
information. Since issues related to the first phase are
usually most concrete and relevant for the child, it is
sensible to start with information about the first phase.
Topics linked to the other two stages could be added ac-
cording to the child’s desires and capacities.
Investing in the assent procedure as such should be a
requirement for pediatric research and (biobank) re-
searchers must invest in the assent procedure. However,
since some children do not have the capacity or desire
to be involved in the research discussion, an affirmative
agreement of the child cannot be a strict requirement. It
is important to note that researchers should still strive
for such an agreement, and that the onus of proof is on
the researcher to justify continuing research without an
affirmative agreement of the child by showing that they
made a proportionate investment in a personalized
assent procedure.
Although personalized assent will require certain ef-
forts, the pediatric (biobank) community must be aware
of its importance. The investment and trust earned, if
maintained, can result in ongoing engagement, import-
ant longitudinal information, and stability in/for the re-
search infrastructure, as well as increased knowledge
among its participants about research activity. Imple-
menting personalized assent will both respect the child
and support biobank research.
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